This is an archive article published on June 25, 2014

Astrazeneca Pharma India falls; Sebi says exchanges to monitor delisting

Shares in Astrazeneca Pharma India Ltd fell 3 per cent.

2 min readMumbaiJun 25, 2014 10:00 AM IST First published on: Jun 25, 2014 at 10:00 AM IST
Shares in Astrazeneca Pharma India fell 3 pct after India's market regulator said stock exchanges will closely monitor the company's delisting process. Reuters Shares in Astrazeneca Pharma India fell 3 pct after India’s market regulator said stock exchanges will closely monitor the company’s delisting process. Reuters

Shares in Astrazeneca Pharma India Ltd fell 3 per cent after India’s market regulator on Tuesday said stock exchanges will closely monitor the company’s delisting process and promptly report any aberrations.

“The promoters of M/s Astrazeneca Pharma India Ltd shall finally purchase shares from public shareholders in the delisting offer only after seeking approval of the Bombay Stock Exchange Limited and National Stock Exchange Limited,” added the Securities and Exchange Board of India in an order.

Latest Comment
Post Comment
Read Comments